Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo …
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: in vitro characterization and in vivo …
HS Chou, M Larsson, MH Hsiao… - Journal of …, 2016 - researchers.mq.edu.au
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo …
HS Chou, M Larsson, MH Hsiao… - Journal of Controlled …, 2016 - scholar.nycu.edu.tw
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo …
HS Chou, M Larsson, MH Hsiao, YC Chen… - JOURNAL OF …, 2016 - ir.lib.nycu.edu.tw
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo …
HS Chou, M Larsson, MH Hsiao, YC Chen… - Journal of Controlled …, 2016 - infona.pl
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo …
HS Chou, M Larsson, MH Hsiao… - … : official journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …
Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo …
HS Chou, M Larsson, MH Hsiao, YC Chen… - Journal of Controlled …, 2015 - europepmc.org
Diabetes is a common global disease that causes immense suffering for individuals and
huge costs for the health care system. To minimize complications such as organ …
huge costs for the health care system. To minimize complications such as organ …